Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-to-moderate Essential Hypertension”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05033535
What this trial is testing

S086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shenzhen People's Hospital 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT06771245
What this trial is testing

A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

Who this might be right for
Mild-to-moderate Essential Hypertension
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 606
Not applicableStudy completedNCT00638911
What this trial is testing

Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 33,247
Post-approval studies (Phase 4)Study completedNCT00333489
What this trial is testing

Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

Who this might be right for
Hypertension
Novartis 551
Post-approval studies (Phase 4)Study completedNCT02495324
What this trial is testing

Fimasartan Achieving SBP Target (FAST) Study

Who this might be right for
Essential,Hypertension
Boryung Pharmaceutical Co., Ltd 369
Large-scale testing (Phase 3)Study completedNCT00344110
What this trial is testing

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 768
Large-scale testing (Phase 3)Study completedNCT01672476
What this trial is testing

A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 293
Post-approval studies (Phase 4)Study completedNCT00147563
What this trial is testing

Compare Effectiveness of Eplerenone vs Atenolol in Reversing the Remodelling Resistance Arteries in Subjects With HT

Who this might be right for
Hypertension
Pfizer 34
Large-scale testing (Phase 3)Study completedNCT07448506
What this trial is testing

Nifedipine Extended-Release in Patients With Mild or Moderate Hypertension

Who this might be right for
High Blood Pressure (& [Essential Hypertension])
Laboratorios Richmond S.A.C.I.F. 50
Testing effectiveness (Phase 2)Study completedNCT01264692
What this trial is testing

Essential Hypertension

Who this might be right for
Essential Hypertension
Idorsia Pharmaceuticals Ltd. 196
Post-approval studies (Phase 4)Study completedNCT00698646
What this trial is testing

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

Who this might be right for
Hypertension
Novartis Pharmaceuticals 384
Large-scale testing (Phase 3)Study completedNCT00262236
What this trial is testing

Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate Hypertension

Who this might be right for
Hypertension
Novartis 693
Large-scale testing (Phase 3)WithdrawnNCT02969265
What this trial is testing

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

Who this might be right for
Hypertension
Takeda
Large-scale testing (Phase 3)Study completedNCT01631227
What this trial is testing

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Who this might be right for
Essential Hypertension
Abbott 665
Post-approval studies (Phase 4)Study completedNCT02031861
What this trial is testing

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Shyndec Pharmaceutical Co., Ltd. 38
Large-scale testing (Phase 3)Study completedNCT00185172
What this trial is testing

Olmesartan in Essential Hypertension

Who this might be right for
Essential Hypertension
Sankyo Pharma Gmbh 2,333
Large-scale testing (Phase 3)Study completedNCT00236665
What this trial is testing

Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
ObesityHypertension
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 531
Testing effectiveness (Phase 2)Study completedNCT00422461
What this trial is testing

A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure

Who this might be right for
Hypertension
Pfizer 135
Large-scale testing (Phase 3)Study completedNCT00413413
What this trial is testing

Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension

Who this might be right for
Hypertension
Novartis Pharmaceuticals 1,134
Large-scale testing (Phase 3)Study completedNCT05359068
What this trial is testing

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Pharmaceuticals Holding Co., Ltd 957
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation